A CT scan of the chest and abdomen with contrast is an X‑ray–based cross‑sectional imaging test where iodinated contrast dye is injected to enhance blood vessels and organs. It produces detailed images to detect infections, tumors, inflammation, bleeding, or vascular problems. The exam usually takes 10–30 minutes, may require fasting and kidney‑function checks, and can cause brief warmth or, rarely, allergic reactions.

A CT (computed tomography) scan uses X‑rays to make detailed cross‑sectional images of a toddler’s head, chest or abdomen. Doctors order it to evaluate trauma, bleeding, infections, congenital anomalies or unexplained symptoms. Scans are fast but involve radiation; teams use low‑dose protocols and may sedate a child to keep them still. Risks and benefits are explained and alternatives considered.

A chest CT primarily images the lungs, mediastinum and chest wall but often includes slices through the upper abdomen just below the diaphragm. That can show parts of the liver, spleen, adrenal glands and upper stomach. For detailed assessment of abdominal organs or suspected abdominal disease, a dedicated CT abdomen (or combined chest–abdomen) is recommended, as chest CT may miss subtle abdominal pathology.

A chest CT alone typically takes about 5–15 minutes from arrival to finish; the actual scan is seconds to a few minutes. An abdomen CT without contrast is similar (about 10–15 minutes). If IV contrast is used, plan 20–45 minutes total for IV placement, injection and any timed phases. A combined chest–abdomen CT with contrast usually takes roughly 20–40 minutes overall.

Most people do not find a chest CT with contrast painful. You may feel a brief pinch when the IV is placed and a warm flushing or metallic taste during injection; some experience mild nausea or temporary discomfort at the injection site. Serious allergic reactions or kidney-related complications are rare but possible; inform staff about allergies, asthma, or kidney problems before the scan.

A chest CT can detect primary lung cancers (non-small cell and small cell), metastatic tumors to the lungs, pleural malignancies including mesothelioma and pleural metastases, thymic tumors in the anterior mediastinum, mediastinal and pulmonary lymphomas, and chest wall tumors. It also identifies pulmonary nodules and lymph node enlargement that suggest malignancy and guides further diagnosis and biopsy.